Supply Issues Medicina Limited Hypodermic and Insulin Syringes (ICN 2855)

• The supply issue with Hypodermic and Insulin Syringes from Medicina Limited is continuing.
• One affected product code is now suspended and unavailable to order:
  • FWC351.
• 13 product codes remain suspended and unavailable to order:
  • FWC341, FWC348, FWC409, FWC338, FWC342, FWC339, FWC346, FWC340, FWC347, FWC344, FWC352, FSW773 and FMK000.
• One affected product code is no longer suspended and is now subject to intermittent supply:
  • FWC345
• One product code remains subject to intermittent supply:
  • FWC343.
• One product code remains subject to Protect Demand Management:
  • FWC349.
• 17 product codes remain affected in total.
• Once stock is received, the following products will be subject Protect Demand Management:
  • FWC341, FWC348, FWC346 and FWC347.
• Products subject to Protect Demand Management are still available to order through NHS Supply Chain. However, trusts are allocated a maximum daily quantity or “threshold” to ensure fair supply of available stock across the NHS.
• Potential indirect alternative products are available to order through our online catalogue for the affected products. However, some of these products may also become subject to intermittent supply with the increase in demand.
• See our Downloads▼ section to access the product listing for further information on the affected product codes and potential alternatives.
• The supply issue is now anticipated to be resolved by 13 June 2025.

• The supply issue with Hypodermic and Insulin Syringes from Medicina Limited is continuing.
• 14 affected product codes are now suspended and unavailable to order:
  • FWC341, FWC348, FWC338, FWC345, FWC342, FWC339, FWC346, FWC340, FWC347, FWC352, FSW773, FMK000, FWC344 and FWC409.
• Once stock is received, the following suspended products will be subject to Protect Demand Management:
  • FWC341, FWC348, FWC346 and FWC347.
• One affected product code remains subject to Protect Demand Management:
  • FWC349.
• Two affected product codes are now subject to intermittent supply:
  • FWC343 and FWC351.
• 17 product codes remain affected in total.
• Potential indirect alternative products are available to order through our online catalogue for the affected products. However, some of these products may also become subject to intermittent supply with the increase in demand.
• See our Downloads ▼ section to access the product listing for further information on the affected product codes.
• The supply issue is now anticipated to be resolved by 15 May 2025.

Change:

• The supplier Medicina Limited has informed us of a supply issue with its Hypodermic and Insulin Syringes.
• There are 17 product codes affected.
• The supply issue is due to an administrative issue on the UKCA certification of the products.

Impact:

• Eight product codes are currently suspended and unavailable to order:
  • FWC338, FWC345, FWC342, FWC339, FWC340, FWC352, FSW773 and FMK000.
• Four product codes are currently subject to intermittent supply:
  • FWC343, FWC351, FWC344 and FWC409.
• Five product codes are subject to Protect Demand Management:
  • FWC341, FWC348, FWC349, FWC346 and FWC347.
• These products are still available to order through NHS Supply Chain. However, trusts are allocated a maximum daily quantity or “threshold” to ensure fair supply of available stock across the NHS.
• Potential indirect alternative products are available to order through our online catalogue for most of the affected products. However, some of these products may also become subject to intermittent supply with the increase in demand.
• See our Downloads ▼ section to access the product listing for further information on the affected product codes and potential alternatives and for a full list of product codes subject to Protect Demand Management.
• The supply issue is anticipated to be resolved by 15 April 2025.

Next Steps:              

• Customers are advised to log into our website to view the product listing for further information on the affected product codes and potential alternatives.
• We will update the ICN when we have further information.
• If you have any further questions, please contact your local NHS Supply Chain Customer Services Advisor.

Please note that due to the clinical nature of these alternative products, we advise you to consult your own clinical experts to ensure suitability for your organisations use of these products.